Inventor · disambiguated record
Stela Gengrinovitch
Also filed as: GENGRINOVITCH STELA
13 granted patents·7 pending applications·111 citations·filing 2002–2021
91Inventor score
Files withBIOSIGHT LTD8GENGRINOVITCH STELA4NEUFELD GERA4TECHNION RES & DEV FOUNDATION3CORAL STAR MEDICAL LTD1
Top patents by PatentIndex Score
20 records- 0193US8168180B2Methods and compositions for modulating angiogenesisNEUFELD GERA·Filed 2009·Granted May 1, 2012·26 cites·13 claims
- 0290US8163494B2Method for assessing metastatic properties of breast cancerNEUFELD GERA·Filed 2003·Granted Apr 24, 2012·23 cites·32 claims
- 0389US7989188B2Conjugates for cancer therapy and diagnosisBIOSIGHT LTD·Filed 2006·Granted Aug 2, 2011·16 cites·12 claims
- 0488US7638127B2Peptide conjugated anti-cancer prodrugsBIOSIGHT LTD·Filed 2006·Granted Dec 29, 2009·6 cites·37 claims
- 0586US8815823B2Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumorsNEUFELD GERA·Filed 2012·Granted Aug 26, 2014·7 cites·19 claims
- 0684US8314060B2Peptide conjugated anti-cancer prodrugsGENGRINOVITCH STELA·Filed 2009·Granted Nov 20, 2012·9 cites·21 claims
- 0781US12064445B2Cytarabine conjugates for cancer therapyBIOSIGHT LTD·Filed 2021·Granted Aug 20, 2024·1 cites·13 claims
- 0880US7135547B2Peptide conjugated anti-cancer prodrugsBIOSIGHT LTD·Filed 2003·Granted Nov 14, 2006·9 cites·23 claims
- 0978US8993278B2Conjugates for cancer therapy and diagnosisGENGRINOVITCH STELA·Filed 2011·Granted Mar 31, 2015·6 cites·10 claims
- 1077US11058701B2Cytarabine conjugates for cancer therapyBIOSIGHT LTD·Filed 2016·Granted Jul 13, 2021·2 cites·14 claims
- 1176US8435800B2Activated labeling reagents and methods for preparing and using the sameGENGRINOVITCH STELA·Filed 2005·Granted May 7, 2013·5 cites·5 claims
- 1273US11104698B2Salts of conjugates for cancer therapyBIOSIGHT LTD·Filed 2016·Granted Aug 31, 2021·1 cites·22 claims
- 1371US2014302499A1Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumorsTECHNION RES & DEV FOUNDATION·Filed 2014·Application pending·0 cites
- 1465US2019040470A1Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumorsTECHNION RES & DEV FOUNDATION·Filed 2018·Application pending·0 cites
- 1564US2012202206A1Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumorsNEUFELD GERA·Filed 2012·Application pending·0 cites
- 1660US12071450B2Salts of conjugates for cancer therapyBIOSIGHT LTD·Filed 2021·Granted Aug 27, 2024·0 cites·6 claims
- 1760US2003114410A1Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosisTECHNION RES & DEV FOUNDATION·Filed 2002·Application pending·0 cites
- 1847US2006115514A1Chelating and binding chemicals to a medical implant, medical device formed, and therapeutic applicationsGENGRINOVITCH STELA·Filed 2005·Application pending·0 cites
- 1944US2020147117A1Combination cancer therapyBIOSIGHT LTD·Filed 2020·Application pending·0 cites
- 2042US2022331135A1Orthopedic braceCORAL STAR MEDICAL LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stela Gengrinovitch files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →